ACM
BIOSU

Atalaya Capital Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Atalaya Capital Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250,000
Closed -$2.52M – 423
2022
Q2 		$2.52M Hold
250,000
– – 0.3% 94
2022
Q1 		$2.5M Hold
250,000
– – 0.27% 97
2021
Q4 		$2.5M Buy
+250,000
New +$2.5M 0.25% 98

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Atalaya Capital Management's BIOSU Position: Q3 2022 in Review

Atalaya Capital Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q3 2022, closing a stake of 250,000 shares — an estimated $2.52M sold.

Atalaya Capital Management first reported a position in BIOSU in Q4 2021 and held it in 3 quarters. The position peaked at $2.52M in Q2 2022. 15 funds tracked by Wall St. Rank hold BIOSU as of Q3 2022.

  • Atalaya Capital Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Atalaya Capital Management sold 250,000 BioPlus Acquisition Corp. Unit shares in Q3 2022, an estimated $2.52M.
  • Atalaya Capital Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
  • Atalaya Capital Management's BioPlus Acquisition Corp. Unit position peaked at $2.52M in Q2 2022.
  • 15 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q3 2022.

Based on Atalaya Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.